J. Warren Huff
2017
In 2017, J. Warren Huff earned a total compensation of $5.1M as Chief Executive Officer at REATA PHARMACEUTICALS, a 12% increase compared to previous year.
Compensation breakdown
| Bonus | $385,500 |
|---|---|
| Option Awards | $4,215,478 |
| Salary | $514,000 |
| Total | $5,114,978 |
Huff received $4.2M in option awards, accounting for 82% of the total pay in 2017.
Huff also received $385.5K in bonus and $514K in salary.
Rankings
In 2017, J. Warren Huff's compensation ranked 1,825th out of 14,666 executives tracked by ExecPay. In other words, Huff earned more than 87.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,825 out of 14,666 | 88th |
Division Manufacturing | 610 out of 5,772 | 89th |
Major group Chemicals And Allied Products | 162 out of 2,075 | 92nd |
Industry group Drugs | 117 out of 1,731 | 93rd |
Industry Pharmaceutical Preparations | 90 out of 1,333 | 93rd |
Source: SEC filing on April 30, 2018.
Huff's colleagues
We found two more compensation records of executives who worked with J. Warren Huff at REATA PHARMACEUTICALS in 2017.
News
REATA PHARMACEUTICALS CEO J Huff's 2021 pay falls 37% to $4M
April 29, 2022
REATA PHARMACEUTICALS CEO J Huff's 2020 pay rises 15% to $6.4M
April 30, 2021
REATA PHARMACEUTICALS CFO Manmeet Soni receives $13M in 2019
April 29, 2020
REATA PHARMACEUTICALS CEO J Huff's 2018 pay falls 82% to $935K
April 30, 2019